KeyStone Magazine features Dr. AmirNovin’s cutting-edge surgical techniques. You can view the article here.
Dr. Aaron Cutler will be joining the INI in July 2014. Dr. Cutler is a fellowship trained neurosurgeon specializing in minimally invasive skull base tumor surgery. His addition to the INI is part of the group’s continued dedication to bringing excellent Neurosurgical care to the region.
Univision headlines Dr. AmirNovin’s Deep Brain Stimulation (DBS) surgery in a two part national segment. Part 1: Part 2: Watch on Univision.com: 1) Part 1 2) Part 2
Dr. Lederhaus speaks on the national stage regarding the growing problem of conflict of interest in spine surgery. Continue Reading….
Bracing Avoids Surgery for Young Patients With Scoliosis: Bracing in high-risk patients with adolescent idiopathic scoliosis (AIS) is associated with a significantly greater likelihood of reaching skeletal maturity with a curve of less than 50 degrees, the degree at which surgery is normally indicated, a new study shows. FULL STUDY HERE
Dr. Ramin AmirNovin’s article on the effects of electrical stimulation on dopamine levels in the brain was accepted for peer-reviewed publication in the journal of Stereotactic Functional Neurosurgery.
Growth, Not Size, of Brain Aneurysms Biggest Risk for Rupture. Brain aneurysms — even small ones — are more likely to rupture if they are growing, a new study has shown. The discovery counters current guidelines and emphasizes the need for regular monitoring and earlier treatment. FULL STUDY HERE
ASCO: No Benefit from Avastin in Glioblastoma. Patients with newly diagnosed glioblastoma lived no longer with the addition of bevacizumab (Avastin) to chemoradiation than they did without it, results of a large multicenter trial showed. SOURCE: Gilbert MR, et al “RTOG 0825: Phase III double-blind, placebo-controlled trial evaluating bevacizumab in patiens with newly diagnosed glioblastoma” ASCO 2013; Abstract 1.